Prevention of hepatitis B virus reactivation in patients with nasopharyngeal carcinoma with lamivudine.

@article{Yeo2005PreventionOH,
  title={Prevention of hepatitis B virus reactivation in patients with nasopharyngeal carcinoma with lamivudine.},
  author={Winnie Yeo and Edwin P Hui and Anthony Tak-cheung Chan and Wing Ho and Kwok Chi Lam and Paul Kay-Sheung Chan and Tony Shu-Kam Mok and Jam J. Lee and Frankie Mo and Philip James Johnson},
  journal={American journal of clinical oncology},
  year={2005},
  volume={28 4},
  pages={
          379-84
        }
}
PURPOSE Although the mainstay of treatment of patients with nasopharyngeal carcinoma (NPC) had been radiotherapy, chemotherapy has increasingly been adopted in conjunction with radiation and in advanced disease. In parts of Asia where NPC is prevalent, it is also known that around 10% of the population has chronic hepatitis B virus (HBV) infection. Cancer patients who are HBV carriers are frequently complicated by HBV reactivation during chemotherapy. This may result in liver damage, which… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 23 CITATIONS

Similar Papers

Loading similar papers…